Cefalexin is the first orally administered synthetic cephalosporin, stable to acid and penicillinase. It is used for the treatment of mild infections caused by susceptible bacteria, particularly respiratory tract infections, urinary tract infections, gynecological and obstetric infections, skin and soft tissue infections, and gonorrhea. Its mechanism of action, antimicrobial spectrum, and indications are similar to those of cephalothin, although its antibacterial potency is weaker than cephalothin. It is not recommended for severe infections due to its oral formulation.